Under the leadership of Calroy’s CEO, Ed Hoyt, his former company Infinity 2 pioneered the development and marketing of the world’s first broad-spectrum digestive enzyme. This innovation helped establish the use of digestive enzymes as a core product category in the complimentary healthcare field.

Bookmark the permalink.